Any therapeutic substance obtained from human blood, including whole blood and other blood components for transfusion, as well as plasma-derived pharmaceutical compounds, is referred to as a blood product. Medicinal (medical therapeutic) products obtained from human blood and plasma donations play an important role in medical care. Every year, blood products that are safe, effective, and of high-quality help to improve and save millions of lives. Inadequate or unsafe blood supplies have a detrimental influence on the ability of critical health services and programmes to offer proper patient care in a variety of acute and chronic illnesses. Access to safe, effective, and quality-assured blood products for all patients who require transfusion is a critical component of a functional health system and essential for patient safety.
Title : Phlebotomy therapy in Sickle cell disease of double heterozygosity HbSC and rare congenital erythrocytosis in hemoglobin variants
Epifania Rita Testa, S Maria degli Angeli Hospital, Italy
Title : The utility of SYNTAX score predictability by electrocardiogram parameters in patients with unstable angina
Hamed Bazrafshan, Shiraz University of Medical Sciences, Iran (Islamic Republic of)
Title : Safety of not withholding Clopidogrel Therapy during the immediate several days pre and post Trans-Urethral Resection of Prostate (TURP) A retrospective cohort study
Ahmed Kamel Abdulhamid, University of Kerbala, Iraq
Title : The contested market of plasma
Jean Mercier Ythier, University of Paris-Panthéon-Assas, France